| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
51,841 |
49,270 |
$4.16M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
42,068 |
39,837 |
$3.30M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
21,606 |
20,896 |
$1.85M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
19,267 |
18,558 |
$1.54M |
| S9083 |
Global fee urgent care centers |
13,502 |
12,124 |
$1.42M |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
12,301 |
11,960 |
$160K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
16,289 |
7,918 |
$151K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
2,574 |
2,521 |
$87K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
4,836 |
4,548 |
$39K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,992 |
3,888 |
$38K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
61 |
56 |
$4K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
48 |
46 |
$3K |
| 87807 |
|
95 |
95 |
$780.45 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
34 |
27 |
$270.19 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
56 |
51 |
$97.52 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
29 |
27 |
$22.60 |
| 81003 |
|
15 |
14 |
$17.01 |
| 99000 |
|
28 |
27 |
$0.00 |